迪瑞医疗(300396) - 2025 Q3 - 季度财报
2025-10-27 08:10
Financial Performance - Revenue for Q3 2025 was CNY 118,056,019.80, a decrease of 60.27% compared to the same period last year[5] - Net profit attributable to shareholders was CNY -58,941,976.28, a decline of 315.63% year-on-year[5] - The company reported a basic and diluted earnings per share of CNY -0.2161, down 315.67% from the previous year[5] - Total operating revenue for the current period was ¥468,750,514.30, a significant decrease from ¥1,175,445,053.92 in the previous period, representing a decline of approximately 60%[35] - Operating profit for the current period was a loss of ¥93,467,863.32, compared to a profit of ¥214,106,161.38 in the previous period[36] - Net profit for the current period was a loss of ¥87,253,663.92, contrasting with a net profit of ¥192,566,604.72 in the previous period[36] - The total comprehensive income for the period attributable to the parent company was -82,064,717.11 yuan, compared to 193,444,937.30 yuan in the previous period[37] - The basic and diluted earnings per share for the current period were both -0.3200 yuan, down from 0.7062 yuan in the previous period[37] Cash Flow - Cash flow from operating activities showed a net outflow of CNY -58,210,987.00, an increase of 80.56% in outflow compared to the previous year[5] - The net cash flow from operating activities increased by CNY 241.16 million, a growth of 80.56%, mainly due to reduced procurement payments and controlled operating expenses[24] - Cash inflows from operating activities totaled 708,497,319.40 yuan, a decrease of 22.2% from 911,446,107.42 yuan in the previous period[38] - Cash outflows from operating activities amounted to 766,708,306.40 yuan, down from 1,210,818,059.95 yuan in the previous period[39] - The net cash flow from operating activities was -58,210,987.00 yuan, an improvement from -299,371,952.53 yuan in the previous period[39] - The net cash flow from investing activities decreased by CNY 272.69 million, a decline of 3627.79%, primarily due to increased cash payments for purchasing structured deposits[24] - The net cash flow from investing activities was -265,176,908.77 yuan, compared to a positive cash flow of 7,516,792.34 yuan in the previous period[39] - The net cash flow from financing activities increased by CNY 58.83 million, a growth of 64.45%, mainly due to a decrease in dividend payments compared to the previous year[24] - Cash inflows from financing activities were 425,000,000.00 yuan, significantly higher than 115,000,000.00 yuan in the previous period[39] - The net cash flow from financing activities was -32,445,646.99 yuan, an improvement from -91,270,818.77 yuan in the previous period[39] Assets and Liabilities - Total assets decreased by 10.38% to CNY 2,784,841,089.87 compared to the end of the previous year[5] - Total assets decreased to ¥2,784,841,089.87 from ¥3,107,533,388.27, reflecting a decline of approximately 10.4%[33] - Total liabilities decreased to ¥889,037,469.80 from ¥1,058,764,060.35, showing a reduction of about 16%[33] - Current liabilities totaled ¥478,180,089.99, down from ¥697,309,012.71, indicating a decrease of approximately 31.4%[33] - Non-current assets decreased to ¥1,074,164,186.50 from ¥1,263,422,546.45, representing a decline of about 15%[33] Shareholder Information - The total number of common shareholders at the end of the reporting period was 16,848[27] - The largest shareholder, Shenzhen Huadexin Run Equity Investment Enterprise, holds 28.34% of shares, amounting to 77,288,400 shares, with 45,600,156 shares pledged[28] Operational Adjustments - The company adjusted pricing policies for key models in response to market competition, impacting short-term sales and profits[8] - The company experienced a 60.12% decrease in operating income due to market environment impacts and business model adjustments[20] - The company aims to conduct a "100-day campaign" in Q4 to improve performance and address challenges[8] - The company reported a significant increase in cash flow from operations, indicating improved operational efficiency and cost control measures[24] Other Financial Metrics - Financial expenses decreased by 610.54% due to increased interest income from maturing structured deposits[21] - Research and development expenses were ¥74,028,362.03, down from ¥95,643,187.59, indicating a reduction of approximately 22.6%[36] - Other comprehensive income after tax for the current period was ¥5,189,997.93, compared to ¥867,601.54 in the previous period, showing a significant increase[36] - The total amount of cash and cash equivalents at the end of the reporting period was CNY 235.01 million, down from CNY 586.68 million at the beginning of the period[31] - The accounts receivable decreased from CNY 441.69 million at the beginning of the period to CNY 335.81 million at the end of the period[31] - The company had a total of 436,936 restricted shares at the end of the reporting period, with 16,382 shares released from restrictions during the period[29] Audit Status - The company’s third-quarter financial report was not audited[41]
纵横股份(688070) - 2025 Q3 - 季度财报
2025-10-27 08:10
成都纵横自动化技术股份有限公司 2025 年第三季度报告 证券代码:688070 证券简称:纵横股份 成都纵横自动化技术股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 | | | | 单位:元 | 币种:人民币 | | --- | --- | --- | --- | --- | | | | 本报告期比 | | 年初至报告 | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 期末比上年 | | | | 减变动幅度 | | 同期增减变 | | | | (%) | | 动幅度(%) | | 营业收入 | 187,705,859.2 ...
永茂泰(605208) - 2025 Q3 - 季度财报
2025-10-27 08:10
永茂泰 2025 年第三季度报告 证券代码:605208 证券简称:永茂泰 上海永茂泰汽车科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误导性 陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息的真 实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 | | | | | | 本报告期比 | | 年初至报告 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 期末比上年 | | | | 减变动幅度 | | 同期增减变 | | | | (%) | | 动幅度(%) | | 营业收入 | 1,655,077,601.36 | 59.65 | 4,274,517,528.54 | ...
中洲特材(300963) - 2025 Q3 - 季度财报
2025-10-27 08:10
Financial Performance - The company's revenue for Q3 2025 was ¥235,434,082.09, representing a decrease of 10.07% compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2025 was ¥21,173,322.84, down 16.73% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥15,898,289.47, a decline of 36.65% compared to the previous year[5] - The basic earnings per share for Q3 2025 was ¥0.05, a decrease of 16.67% from the same period last year[5] - Total operating revenue decreased to ¥688,268,402.05 from ¥807,141,733.63, representing a decline of approximately 14.7% year-over-year[22] - Net profit for the period was ¥53,837,768.26, down from ¥72,793,726.49, reflecting a decrease of approximately 26.0% year-over-year[23] - Basic and diluted earnings per share decreased to ¥0.12 from ¥0.16, a decline of 25.0% year-over-year[24] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,842,278,581.07, a decrease of 0.85% from the end of the previous year[5] - Total assets amounted to ¥1,842,278,581.07, slightly down from ¥1,858,146,205.53, indicating a decrease of about 0.9%[20] - Current liabilities totaled ¥556,472,234.06, down from ¥637,742,171.53, a decrease of approximately 12.7% year-over-year[20] - Long-term borrowings increased to ¥165,810,647.34 from ¥136,370,476.98, an increase of about 21.6% year-over-year[20] Cash Flow - The cash flow from operating activities for the year-to-date was -¥80,369,272.43, a significant decline of 1,119.11% compared to the previous year[10] - Operating cash inflow for the current period was ¥722,521,472.84, an increase of 45.5% from ¥496,373,174.47 in the previous period[25] - Operating cash outflow for the current period was ¥802,890,745.27, up from ¥502,965,651.51, resulting in a net cash flow from operating activities of -¥80,369,272.43 compared to -¥6,592,477.04 previously[26] - The net increase in cash and cash equivalents for the current period was -¥60,326,328.56, contrasting with an increase of ¥1,249,161.18 in the previous period[26] - The ending balance of cash and cash equivalents was ¥30,681,353.78, down from ¥65,984,708.64 at the end of the previous period[26] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 46,786[12] - The largest shareholder, Feng Mingming, holds 35.54% of the shares, totaling 162,997,128 shares[13] - The total number of restricted shares held by major shareholders increased to 180,300,746, with a total of 59,424,089 shares added during the period[15] - The total number of shares held by the top ten unrestricted shareholders is 180,300,746, with Feng Mingming and Shanghai DunJia Investment Management Co., Ltd. being the largest holders[13] - The company has a total of 127,068,007 restricted shares at the beginning of the period, with 6,191,350 shares released during the current period[15] - The company has not reported any changes in the status of major shareholders participating in margin financing or securities lending[13] Expenses and Income - The company reported a 108.04% increase in financial expenses, totaling ¥4,848,216.36, due to increased financing scale[10] - The company experienced a 132.65% increase in other income, amounting to ¥8,975,399.26, primarily from government subsidies[10] - Research and development expenses were ¥37,782,510.21, compared to ¥35,778,327.59, an increase of approximately 5.6% year-over-year[23] - Other income increased to ¥8,975,399.26 from ¥3,857,858.02, reflecting a growth of about 132.0% year-over-year[23] - Employee compensation payments rose to ¥124,404,103.98 from ¥101,889,867.80, reflecting a 22.0% increase[26] - Tax payments remained relatively stable, with a slight increase to ¥13,310,524.32 from ¥13,230,852.32[26] Audit and Reporting - The company reported a significant decrease in cash and cash equivalents, with a balance of ¥39,992,431.32 compared to ¥119,473,901.91 at the beginning of the period, representing a decline of approximately 66.5%[18] - The company’s financial report for the third quarter was not audited, indicating a need for caution in interpreting the results[28]
道道全(002852) - 2025 Q3 - 季度财报
2025-10-27 08:10
证券代码:002852 证券简称:道道全 公告编号:2025-056 道道全粮油股份有限公司 2025 年第三季度报告 道道全粮油股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 道道全粮油股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入(元) | 1,605,021,264.26 | 11.25% | 4,397, ...
世嘉科技(002796) - 2025 Q3 - 季度财报
2025-10-27 08:05
苏州市世嘉科技股份有限公司 2025 年第三季度报告 证券代码:002796 证券简称:世嘉科技 公告编号:2025-061 苏州市世嘉科技股份有限公司 2. 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季 度报告中财务信息的真实、准确、完整。 3. 第三季度财务会计报告未经过审计。 1 苏州市世嘉科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一)主要会计数据和财务指标 公司无需追溯调整或重述以前年度会计数据 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示: 1. 董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、 误导性陈述或重大遗漏,并承担个别和连带的法律责任。 | 项目 | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 期增减 | | 比上年同期增减 | | 营业收入(元) | 262,945,702.48 | 7.48% | 673,806 ...
宝武镁业(002182) - 2025 Q3 - 季度财报
2025-10-27 08:05
宝武镁业科技股份有限公司 2025 年第三季度报告 证券代码:002182 证券简称:宝武镁业 公告编号:2025-44 宝武镁业科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息 的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 宝武镁业科技股份有限公司 2025 年第三季度报告 一、主要财务数据 | | | | 单位:元 | | --- | --- | --- | --- | | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | 非流动性资产处置损益(包括已计提资产减值 | -314,551.94 | -83,066.89 | | | 准备的冲销部分) | | | | | 计入当期损益的政府补助(与公司正常经营业 务密切相关、符合国家政 ...
联发股份(002394) - 2025 Q3 - 季度财报
2025-10-27 08:05
Financial Performance - The company's revenue for Q3 2025 was ¥947,227,964.77, representing a decrease of 15.71% compared to the same period last year[6]. - Net profit attributable to shareholders for the same period was ¥79,359,977.99, down 2.39% year-on-year, while net profit after deducting non-recurring gains and losses increased by 87.21% to ¥44,149,222.48[6]. - Year-to-date revenue reached ¥2,973,980,077.03, a decline of 17.24% compared to the previous year, while year-to-date net profit attributable to shareholders surged by 101.90% to ¥263,557,123.19[6]. - Total operating revenue for the current period is ¥2,973,980,077.03, a decrease of 17.2% from ¥3,593,350,060.52 in the previous period[20]. - Net profit for the current period is ¥265,290,275.98, an increase of 97.9% compared to ¥134,138,092.10 in the previous period[21]. - Earnings per share (basic and diluted) increased to ¥0.8142 from ¥0.4033, representing a growth of 102.2%[21]. Assets and Liabilities - The company's total assets at the end of the reporting period were ¥6,086,197,049.73, reflecting a 1.83% increase from the end of the previous year[6]. - The total current assets amount to ¥3,607,314,369.82, an increase from ¥3,500,201,478.57 at the beginning of the period[17]. - Total assets reached ¥6,086,197,049.73, up from ¥5,976,737,150.12[18]. - Total liabilities decreased to ¥1,709,735,402.38 from ¥1,814,558,019.54[18]. - Total equity attributable to shareholders of the parent company increased to ¥4,323,557,393.86 from ¥4,105,815,492.86, a rise of 5.3%[20]. - Total liabilities and equity reached ¥6,086,197,049.73, compared to ¥5,976,737,150.12 in the previous period, marking an increase of 1.8%[20]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥563,467,526.07, showing a growth of 4.92%[6]. - Cash flow from operating activities generated a net amount of ¥563,467,526.07, up from ¥537,055,238.28 in the previous period[22]. - Cash inflow from investment activities totaled ¥4,697,666,853.41, compared to ¥4,401,886,687.60 in the previous period, indicating a growth of 6.7%[22]. - Cash outflow for investment activities was ¥4,503,307,945.97, slightly increased from ¥4,453,126,971.77 in the previous period[22]. - Cash inflow from financing activities was ¥1,035,823,342.18, up from ¥870,316,132.72 in the previous period, reflecting a growth of 19.0%[22]. - The net increase in cash and cash equivalents for the period was $375.72 million, compared to $198.07 million, showing a significant increase of approximately 89.7%[24]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,954[13]. - Jiangsu Lianfa Group Co., Ltd. holds 40.45% of shares, totaling 130,934,100 shares, with 35,000,000 shares pledged[13]. - The company has no preferred shareholders or significant changes in shareholder relationships reported[15]. Financial Management - The company reported a significant increase in cash and cash equivalents, which rose by 72.98% to ¥870,915,514.36 due to the redemption of financial products[11]. - The company’s short-term borrowings decreased by 38.94% to ¥358,176,441.70, indicating improved liquidity management[11]. - The company’s investment income for the period was ¥18,572,034.02, a substantial increase of 159.83% compared to the previous year[12]. - The company’s financial expenses decreased by 43.92% to ¥15,837,425.97, primarily due to reduced interest expenses compared to the same period last year[12]. - Short-term borrowings decreased significantly to ¥358,176,441.70 from ¥586,563,771.71, a reduction of approximately 38.88%[18]. Other Information - The third quarter financial report was not audited, which may affect the reliability of the reported figures[25]. - The company plans to implement new accounting standards starting in 2025, which may impact financial reporting[25]. - The board of directors meeting was held on October 28, 2025, indicating ongoing governance and oversight activities[26].
爱朋医疗(300753) - 2025 Q3 - 季度财报
2025-10-27 08:05
Financial Performance - The company's operating revenue for the third quarter was ¥92,480,163.03, a decrease of 2.95% compared to the same period last year[4] - Net profit attributable to shareholders was ¥7,894,887.15, an increase of 255.22% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥5,836,908.38, up 217.80% from the previous year[4] - The company's net profit attributable to shareholders decreased to ¥170,355,620.81 from ¥190,032,945.68, a drop of 10.4%[17] - The net profit for the current period is -12,288,412.34, compared to a net profit of 3,871,895.24 in the previous period, indicating a significant decline[19] - Operating profit for the current period is -20,717,716.75, while the previous period reported an operating profit of 12,974,498.00, reflecting a substantial decrease[19] - The total comprehensive income for the current period is -12,288,412.34, compared to 3,871,895.24 in the previous period, showing a significant drop[19] - The basic and diluted earnings per share for the current period are both -0.0911, compared to 0.0302 in the previous period[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥839,641,329.18, a decrease of 2.76% from the end of the previous year[4] - The company's cash and cash equivalents decreased to ¥145,673,239.26 from ¥201,635,257.87, a decline of 27.8%[15] - Total assets decreased to ¥839,641,329.18 from ¥863,485,234.50, a reduction of 2.8%[16] - Total liabilities decreased slightly to ¥153,564,161.15 from ¥155,622,128.21, a decline of 1.3%[16] - Current liabilities totaled ¥127,060,432.65, a slight increase from ¥125,619,973.03, reflecting a growth of 1.1%[16] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥50,180,829.57, a decrease of 50.53% year-on-year[4] - Cash flow from operating activities shows a net outflow of -50,180,829.57, compared to a net outflow of -33,336,214.47 in the previous period, indicating worsening cash flow conditions[20] - Cash flow from investing activities shows a net outflow of -17,903,425.18, compared to -96,933,485.73 in the previous period, indicating improved investment cash flow[21] - Cash flow from financing activities resulted in a net inflow of 12,122,236.14, contrasting with a net outflow of -4,036,038.24 in the previous period, showing a positive shift in financing[21] - The company received 73,700,000.00 in borrowings during the current period, an increase from 48,400,000.00 in the previous period, indicating increased leverage[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 22,128[10] - Wang Ningyu holds 28.62% of shares, totaling 36,069,811 shares, with 8,600,000 shares pledged[10] - Zhang Zhihui holds 10.46% of shares, totaling 13,179,428 shares[10] - The total number of restricted shares at the end of the period is 38,153,964, with 5,472,212 shares released during the period[12] - The total number of shareholders for preferred shares is not applicable[11] Investments and Acquisitions - The company reported a significant increase in investment income by 339.15% due to higher earnings from joint ventures[8] - The company experienced a 400.35% increase in net cash flow from financing activities, primarily due to new short-term borrowings[8] - The company’s goodwill increased by 44.12% due to the acquisition of a subsidiary[8] - The company reported a significant increase in goodwill to ¥78,842,117.94 from ¥54,705,759.84, an increase of 43.9%[16] - Long-term equity investments increased to ¥58,782,533.88 from ¥52,393,867.86, a growth of 12.5%[15] Research and Development - Research and development expenses rose to ¥28,911,852.32, an increase of 23.4% compared to ¥23,409,768.84 in the previous period[18] - The company’s subsidiary obtained a medical device registration certificate for portable EEG machines, enhancing its product offerings[13] - The company plans to expand its market presence with new medical technology products[13] Management and Governance - The company has completed the election of the board of directors and the appointment of senior management[13] - Senior management member Li Qing reduced his shareholding by 119,174 shares, representing 0.0945% of the total share capital[13] Reporting Period - The company's financial report is prepared as of September 30, 2025[14] - Total operating revenue for the current period was ¥251,646,851.61, a decrease of 8.4% compared to ¥274,753,514.10 in the previous period[18] - Total operating costs increased to ¥281,294,518.85, up 3.4% from ¥271,029,178.03 in the previous period[18]
腾远钴业(301219) - 2025 Q3 - 季度财报
2025-10-27 08:05
Financial Performance - The company's revenue for Q3 2025 reached ¥2,219,425,314.62, representing a year-over-year increase of 31.60%[4] - Net profit attributable to shareholders for the same period was ¥282,078,974.99, up 47.84% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥270,775,455.57, reflecting a 45.42% increase year-over-year[4] - Total operating revenue for the current period reached ¥5,751,865,530.03, an increase of 17.6% compared to ¥4,889,154,064.91 in the previous period[20] - Net profit for the current period was ¥745,359,579.52, representing a 20.7% increase from ¥617,451,411.41 in the previous period[21] - The total revenue attributable to the parent company's owners was approximately ¥669.8 million, an increase from ¥585.7 million in the previous period, representing a growth of about 14.5%[22] - Basic and diluted earnings per share both increased to ¥2.55 from ¥2.10, reflecting a growth of approximately 21.4%[22] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥12,233,124,220.71, a 14.27% increase from the end of the previous year[4] - The total assets increased to ¥12,233,124,220.71, compared to ¥10,705,210,879.03 in the previous year, reflecting a growth of 14.2%[18] - Total liabilities rose to ¥2,881,652,408.36, up from ¥1,905,063,981.52, indicating a growth of 51.2%[18] - The total liabilities and equity reached ¥12,233,124,220.71, up from ¥10,705,210,879.03, indicating a growth of 14.2%[18] Shareholder Information - The total number of common stock shareholders at the end of the reporting period is 28,910[11] - The largest shareholder, Luo Jie, holds 22.43% of shares, totaling 66,093,066 shares[11] - The total number of restricted shares at the end of the period is 90,071,820, down from 126,836,056, indicating a reduction of approximately 29%[13] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥764,572,100.73, a significant increase of 796.97%[4] - Net cash flow from operating activities was ¥764.6 million, significantly up from ¥85.2 million in the previous period, indicating a substantial improvement in operational efficiency[23] - Cash inflow from operating activities totaled ¥7.06 billion, compared to ¥5.28 billion in the prior period, marking an increase of approximately 33.9%[23] - Cash outflow from investing activities was ¥389.5 million, slightly higher than ¥368.9 million in the previous period, resulting in a net cash flow from investing activities of -¥385.9 million[23] - Cash inflow from financing activities was ¥387.7 million, down from ¥659.2 million in the previous period, indicating a decrease of approximately 41.1%[23] - The net cash flow from financing activities was -¥126.8 million, an improvement from -¥422.8 million in the previous period, showing a reduction in cash outflow[23] - The ending balance of cash and cash equivalents was ¥3.58 billion, an increase from ¥3.04 billion at the end of the previous period, reflecting a growth of approximately 17.6%[23] Expenses - Research and development expenses for the year-to-date were ¥126,104,846.20, up 51.88% from the previous year[9] - The company reported a 90.14% increase in management expenses, totaling ¥322,580,168.01, primarily due to business growth and increased personnel costs[9] - Research and development expenses for the current period were ¥126,104,846.20, an increase from ¥83,027,149.77 in the previous period, reflecting a growth of 52.0%[20] Other Financial Metrics - The weighted average return on equity was 3.06% for the reporting period, an increase of 0.83% compared to the previous year[4] - The company reported a decrease in other comprehensive income, with a net amount of -¥81,350,213.23 compared to -¥31,751,486.64 in the previous period[21] - The company's financial expenses showed a significant improvement, with a net financial cost of -¥17,411,801.09 compared to -¥29,324,688.16 in the previous period[20] Investments and Projects - The company has established a joint venture, New Cheng New Energy Investment Co., Ltd., and is currently conducting construction for a project with an annual capacity of 30,000 tons of copper and 2,000 tons of cobalt[14] Audit and Accounting Standards - The company did not undergo an audit for the third quarter financial report[24] - The company plans to implement new accounting standards starting in 2025, which may impact financial reporting[24]